Evotec SE acquired Campus Levi-Montalcini from GlaxoSmithKline plc for 1.
Evotec SE (XTRA:EVT) completed the acquisition of Campus Levi-Montalcini from GlaxoSmithKline plc (LSE:GSK) for 1 on July 1, 2021.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,675 GBX | +0.30% | +1.39% | +15.43% |
05:01pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
04:50pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
1st Jan change | Capi. | |
---|---|---|
+15.43% | 85.64B | |
+32.73% | 664B | |
+29.29% | 567B | |
-7.07% | 354B | |
+19.19% | 330B | |
+4.36% | 286B | |
+13.38% | 234B | |
+5.15% | 199B | |
-9.78% | 196B | |
-4.94% | 148B |